In nonhospitalized, unvaccinated adults with COVID-19, molnupiravir reduced hospitalization or death at 29 d. | Ann Intern Med;175(4): JC40, 2022 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

In nonhospitalized, unvaccinated adults with COVID-19, molnupiravir reduced hospitalization or death at 29 d.

Sacks, Henry S.

Sacks HS; Icahn School of Medicine at Mount Sinai, New York, New York, USA (H.S.S.).

Ann Intern Med ; 175(4): JC40, 2022 04.

Article in English | MEDLINE | ID: covidwho-1776565

ABSTRACT

ABSTRACT

SOURCE CITATION Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med. 2022;386509-20. 34914868.

Subject(s)

COVID-19; Adult; Cytidine/analogs & derivatives; Hospitalization; Humans; Hydroxylamines/adverse effects; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Adult / Humans Language: English Journal: Ann Intern Med Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Adult / Humans Language: English Journal: Ann Intern Med Year: 2022 Document Type: Article